AI assistant
Sending…
Cigna Group — Director's Dealing 2020
Nov 7, 2020
29918_dirs_2020-11-06_9b35de2e-fcef-4a3a-a511-654faf8c7c6f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2020-11-04
Reporting Person: WENTWORTH TIMOTHY C (CEO Evernorth)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-04 | Common Stock, $.01 Par Value | M | 41357.0000 | $160.6623 | Acquired | 88361.0000 | Direct |
| 2020-11-04 | Common Stock, $.01 Par Value | S | 41357.0000 | $195.4600 | Disposed | 47004.0000 | Direct |
| 2020-11-05 | Common Stock, $.01 Par Value | M | 3849.0000 | $160.6623 | Acquired | 50853.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-04 | Employee Stock Option (Right to Buy) | $160.6623 | M | 41357.0000 | Disposed | 2021-03-05 | Common Stock, $.01 Par Value (41357.0000) | Direct |
| 2020-11-05 | Employee Stock Option (Right to Buy) | $160.6623 | M | 3849.0000 | Disposed | 2021-03-05 | Common Stock, $.01 Par Value (3849.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $.01 Par Value | 29083.0000 | Indirect |
Footnotes
F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2020.
F2: This option was granted on March 5, 2014. The option vested in three equal annual installments on February 28, 2015, February 28, 2016, and February 28, 2017.
More from Cigna Group
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4